Telomir Pharmaceuticals (TELO) Short Interest Ratio & Short Volume $5.15 +0.03 (+0.59%) (As of 09/6/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Telomir Pharmaceuticals Short Interest DataTelomir Pharmaceuticals (TELO) has a short interest of 128,200 shares, representing 0.75% of the float (the number of shares available for trading by the public). This marks a 2.40% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.9, indicating that it would take 1.9 days of the average trading volume of 129,450 shares to cover all short positions.Current Short Interest128,200 sharesPrevious Short Interest125,200 sharesChange Vs. Previous Month+2.40%Dollar Volume Sold Short$519,210.00Short Interest Ratio1.9 Days to CoverLast Record DateAugust 15, 2024Outstanding Shares29,610,000 sharesFloat Size17,000,000 sharesShort Percent of Float0.75%Today's Trading Volume86,423 sharesAverage Trading Volume129,450 sharesToday's Volume Vs. Average67% Short Selling Telomir Pharmaceuticals? Sign up to receive the latest short interest report for Telomir Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartTELO Short Interest Over TimeTELO Days to Cover Over TimeTELO Percentage of Float Shorted Over Time Ad Golden CrestBiden's Successor: The Radical Threat to YOUR Savings!Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a plan to take over your money and leave you with nothing. Higher taxes, government control, and a digital dollar to track every penny you spend. This isn't about convenience; it's about CONTROL.>> Get Your FREE Wealth Protection Guide << Telomir Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 8/15/2024128,200 shares $519,210.00 +2.4%0.8%1.9 $4.05 7/31/2024125,200 shares $451,972.00 +1.6%0.7%3.2 $3.61 7/15/2024123,200 shares $510,048.00 No Change0.7%3 $4.14 TELO Short Interest - Frequently Asked Questions What is Telomir Pharmaceuticals' current short interest? Short interest is the volume of Telomir Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of August 15th, traders have sold 128,200 shares of TELO short. 0.75% of Telomir Pharmaceuticals' shares are currently sold short. Learn More on Telomir Pharmaceuticals' current short interest. What is a good short interest ratio for Telomir Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TELO shares currently have a short interest ratio of 2.0. Learn More on Telomir Pharmaceuticals's short interest ratio. What is a good short interest percentage for Telomir Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.75% of Telomir Pharmaceuticals' floating shares are currently sold short. Is Telomir Pharmaceuticals' short interest increasing or decreasing? Telomir Pharmaceuticals saw a increase in short interest in August. As of August 15th, there was short interest totaling 128,200 shares, an increase of 2.4% from the previous total of 125,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Telomir Pharmaceuticals' float size? Telomir Pharmaceuticals currently has issued a total of 29,610,000 shares. Some of Telomir Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Telomir Pharmaceuticals currently has a public float of 17,000,000 shares. How does Telomir Pharmaceuticals' short interest compare to its competitors? 0.75% of Telomir Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Telomir Pharmaceuticals: Corbus Pharmaceuticals Holdings, Inc. (10.45%), iTeos Therapeutics, Inc. (8.93%), IGM Biosciences, Inc. (27.83%), REGENXBIO Inc. (11.59%), GH Research PLC (4.80%), Arcturus Therapeutics Holdings Inc. (22.11%), Silence Therapeutics plc (1.17%), Pharvaris (0.73%), Annexon, Inc. (7.87%), ProKidney Corp. (14.31%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.23 billion), Aptiv PLC ($2.50 billion), Royal Caribbean Cruises Ltd. ($2.48 billion), Paychex, Inc. ($2.25 billion), Moderna, Inc. ($2.17 billion), Cencora, Inc. ($2.12 billion), Tractor Supply ($1.93 billion), Onsemi ($1.82 billion), International Paper ($1.81 billion), and Rivian Automotive, Inc. ($1.72 billion). View all of the most shorted stocks. What does it mean to sell short Telomir Pharmaceuticals stock? Short selling TELO is an investing strategy that aims to generate trading profit from Telomir Pharmaceuticals as its price is falling. TELO shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Telomir Pharmaceuticals? A short squeeze for Telomir Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TELO, which in turn drives the price of the stock up even further. How often is Telomir Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TELO, twice per month. The most recent reporting period available is August, 15 2024. More Short Interest Resources from MarketBeat Related Companies: CRBP Short Squeeze ITOS Short Squeeze IGMS Short Squeeze RGNX Short Squeeze GHRS Short Squeeze ARCT Short Squeeze SLN Short Squeeze PHVS Short Squeeze ANNX Short Squeeze PROK Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TELO) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Telomir Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Telomir Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.